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On average, just three ethics consultations are performed per year in U.S. hospitals (Fox, 
Myers & Pearlman, 2007). Given the 
likelihood that your hospital will have 
so few ethics consultation requests 
each year, how much professional 
energy should an institution expend 
maintaining an ethics consultation 
service?  Typically, such consultations 
are provided, in whole or in part, 
by members of a health care ethics 
committee. In Maryland, such 
committees (i.e., “patient care advisory 
committees”) are mandated by law. 
The Joint Commission looks to ethics 
committees as one mechanism for 
addressing ethical issues within an 
institution. But how effective is the 
ethics committee in “addressing ethical 
issues” at the institution it serves? And 
what role should formal ethics case 
consultation play in this process?
Some institutions have explored 
alternatives to the types of infrequent, 
conflict-laden ethics consultations 
quantified by Fox and colleagues 
(2007).  Columbia St. Mary’s hospital 
offers one example. The institution’s 
staff attempted to identify patient 
care situations that would benefit 
from ethics consultations closer to 
a patient’s hospital admission. They 
DIFFERING MODELS OF 
ETHICS CONSULTATION AND 
THEIR LIMITATIONS
predicted that such consultations 
would be more advisory in nature—
that is, involving interpretations of 
the Catholic Hospital Association’s 
Ethical and Religious Directives, or 
clarification of established hospital 
ethics policy and procedures. Mark 
Repenshek, PhD, Health Care Ethicist 
at Columbia St. Mary’s (CSM’s) 
Health System, developed a database 
describing ethics consultations 
performed between 2003 and 2007. 
Of 179 consultations performed 
during this time at CSM’s four acute-
care Wisconsin hospitals (totaling 
about 650 beds), “ethics advisement” 
accounted for 152 of 179 total requests 
(84.9%), ethics committee consultation 
accounted for 24 of 179 requests 
(13.4%), and retrospective case review 
accounted for three of 179 requests 
(1.7%). Repenshek noted that, with 
increased awareness of ethics services 
available, retrospective case review 
is being increasingly requested—that 
is, “targeted education requested 
by a unit/department with the goal 
of organizational process change 
or development in response to the 
consultation requested” (p. 12). But 
more notably, the relatively low number 
of formal ethics case consultations is 
dwarfed by the much higher number 
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one of several activities that an 
ethics consultant may engage in. 
Other examples include mentoring, 
lecturing, scholarly writing, 
policy review, etc. Many ethics 
consultants also engage in “curbside 
consultations.” DeRenzo and 
colleagues report an increase in such 
consultations in hospital corridors as 
a result of the increased presence of 
bioethicists at ICU rounds. The issue 
of “advisory consults” or “curbside 
consults,” however, raises questions 
about due process, procedural 
standards, and fairness. 
Consider an analogy to the field 
of cardiology. You are a general 
internist. You ask a cardiologist 
colleague a question related to 
treating atrial fibrillation, because 
you currently have a patient with this 
condition. Your colleague gives you 
a general opinion about medications 
used to treat atrial fibrillation. This 
is not a cardiology consult, because 
your colleague has not evaluated 
the patient’s medical history and 
conducted a thorough exam. He or 
The Maryland Healthcare Ethics Committee Network (MHECN) is a 
membership organization, established by the Law and Health Care Program 
at the University of Maryland School of Law. The purpose of MHECN is 
to facilitate and enhance ethical reflection in all aspects of decision making 
in health care settings by supporting and providing informational and 
educational resources to ethics committees serving health care institutions 
in the state of Maryland. The Network will achieve this goal by:
   • Serving as a resource to ethics committees as they investigate  
 ethical dilemmas within their institution and as they strive to assist  
 their institution to act consistently with its mission statement;
   • Fostering communication and information sharing among Network  
      members;
   • Providing educational programs for ethics committee members, other 
      healthcare providers, and members of the general public on ethical  
 issues in health care; and
   • Conducting research to improve the functioning of ethics committees 
 and ultimately the care of patients in Maryland.
of “ethics advisements.” Is this 
happening elsewhere? 
A cousin to ethics advisement 
might be found in the practice of 
ethics rounding, which was imple-
mented by DeRenzo and her fel-
low bioethicists at various MedStar 
hospitals. The participation of a 
bioethicist in ICU rounds brings 
ethical issues to the forefront, and al-
lows the ethics consultant to counsel 
and educate health care providers at 
the bedside, demonstrating utility of 
ethics expertise in everyday patient 
care decision-making. This increases 
awareness of the ethics consult ser-
vice, and achieves a more proactive 
ethics intervention that may reduce 
escalation of conflict that so often 
typifies formal case consultations 
(Derenzo, Mokwunye, & Lynch, 
2006). 
The upcoming second edition of 
ASBH’s Core Competencies for 
Health Care Ethics Consultation 
considers rounding in an ICU to 
be something different from ethics 
consultation, both representing 
Differing Models of Ethics Consultation
Cont. from page 1
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Note
1Repenshek and colleagues were 
able to show that hospital length of 
stay was reduced by half for patients 
who had an ethics consultation (from 
36.1 days in 2003 to 18.23 days in 
2007). Schneiderman and colleagues 
had similar findings; Schneiderman, 
et al. (2003), “Effect of ethics 
consultations on non-beneficial 
life-sustaining treatments in the 
intensive care setting: A randomized 
controlled trial.” JAMA 290, 1166-
1172.
she has not entered a note in the 
patient’s medical record. It might 
meet your needs. It might not.
Similarly, if a physician asks an 
ethics consultant a question about 
a patient, she may be seeking gen-
eral insight or information that 
is not dependent on the patient’s 
particular circumstances (e.g., “I’m 
writing a DNR order for a patient 
based on a medically ineffective-
ness certification. Do I have to tell 
the surrogate?”). This would be an 
example of what Repenshek would 
call an “ethics advisement” request, 
and what Fox and colleagues (2006) 
at the National Center for Ethics in 
Health Care would call a “non-case 
consultation” request. Or, the phy-
sician may be seeking input of the 
ethics expert on a particular patient’s 
plan of care (e.g., “I am thinking 
of stopping Mr. W’s tube feedings 
based on medical ineffectiveness. Is 
this OK?”). This would be an exam-
ple of a “case consultation” request. 
Each should be handled by a well-
informed ethics consultant who is 
mindful of how particular details of a 
case may dictate ethically appropri-
ate options. But any recommendation 
or advice intended to directly influ-
ence a particular patient’s plan of 
care should be approached as a “case 
consultation,” in which the consul-
tant follows a standard process (e.g., 
gathering facts, visiting the patient, 
convening a meeting of stakeholders, 
if indicated, entering an ethics note 
in the patient’s medical record, etc.).
Given the range of alternatives to 
ethics consultation described above, 
one may ask whether ethics commit-
tees should look beyond formal case 
consultation as the most effective 
method of addressing ethical issues 
at their institutions. But this raises 
questions about whether ethics com-
mittees have the skills and staffing 
resources necessary to implement 
these alternative approaches. While 
the institutions at which Repenshek 
and DeRenzo are affiliated have 
trained, paid ethics consultants to 
staff their services, Fox and col-
leagues (2007) found that only 16% 
of hospitals provide salary support 
specifically for ethics consultation. 
Many think hospitals would be better 
off making a financial commitment 
to support ethics consultation at their 
institutions. Ethics consultation is 
best positioned to produce value for 
a health care organization when it 
is more readily accessible to health 
care providers at the bedside, and 
when it is provided by qualified eth-
ics consultants. Providing services 
beyond mere case consultation, such 
as those described above, could 
improve staff morale and perceptions 
regarding the ethical climate of the 
organization, lower perceived moral 
distress among staff, lower staff 
turnover, improve palliative care 
access and outcomes among patients, 
and reduce resources spent on non-
beneficial interventions.1  Perhaps 
hospital administrators and ethics 
committee members are content with 
the status quo provided by the ma-
jority of all-volunteer, low volume 
ethics consultation services, rather 
than considering the value added 
from providing the other types of 
ethics services described above.  Or, 
perhaps all-volunteer ethics commit-
tees are capable of branching out to 
provide such services with adequate 
training and leadership support. But 
it’s more likely that the positive 
impact of health care ethics commit-
tees and ethics consult services will 
be the greatest for those institutions 
whose budgets support a range of 
services that address ethical issues 
throughout the institution.
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ASBH TO RELEASE 2ND EDITION
OF CORE COMPETENCIES
In February, 2006, the American Society for Bioethics and Humanities (ASBH) Board 
approved a motion to produce 
an updated version of the Core 
Competencies for Health Care 
Ethics Consultation. The Core 
Competencies Update Task Force 
was formed for this purpose. 
From November, 2009 through 
January 31, 2010, a draft of the 2nd 
edition of the Core Competencies 
was publicly available for open 
comment at http://www.asbh.org. 
Feedback is now being reviewed 
and, where necessary, changes are 
being made to the final draft. The 
newly formed ASBH Standing 
Committee on Clinical Ethics 
Consultation Affairs will review 
the final draft later this year, and 
provide a recommendation that 
the ASBH Board approve it for 
publication. 
Major changes from the first 
edition, which was published in 
1998, include:
1.  Boundaries of Health Care 
Ethics Consultation (HCEC) 
clarified. HCEC was distinguished 
from other activities typically 
performed by health care ethicists, 
such as developing ethics-related 
organizational policies, serving 
on organizational committees, and 
producing scholarly work. This 
decision was based on a shared 
understanding that the competencies 
required for ethics consultation 
are different from competencies 
required for these other activities.
 
2.  Scope of HCEC clarified. The 
2nd edition clarifies that HCEC is 
not necessarily limited to what is 
often thought of as clinical ethics 
(e.g., issues relating to end-of-life 
care), but may encompass a broad 
range of content domains including, 
for example, ethical practices in 
resource allocation, business and 
management, and research. Clinical 
ethics, organizational ethics, 
professional ethics, business ethics, 
research ethics, medical ethics, 
and the like, are thus depicted as 
“sub-specialties” of health care 
ethics, in recognition of the fact that 
some health care ethics consultants 
will limit their practice to one or 
more of these areas, while other 
ethics consultants may respond to 
questions across the full spectrum 
of health care ethics. 
3.  Content related to “organiza-
tional ethics” integrated into Section 
1. The 2nd edition no longer recog-
nizes “clinical ethics” and “organi-
zational ethics” as distinct entities.  
The decision was made to eliminate 
this distinction because of both the 
wide divergence of opinion regard-
ing the meaning of these terms, and 
recognition of the increasing trend 
to integrate ethics throughout an or-
ganization. Thus, content related to 
“non-case consultations” was added 
to Section 1, as well as how the eth-
ics consultation service collaborates 
with other services within a health 
care institution.
4.  Distinction made between 
“case” and “non-case” consulta-
tions. The 2nd edition divides 
HCECs into two mutually exclusive 
categories: ethics consultations that 
pertain to a specific, active patient 
case (referred to as “case consulta-
tions”) and all other ethics consulta-
tions (“non-case consultations”).  
The Task Force considered a variety 
of different alternatives for catego-
rizing ethics consultation activities 
and engaged in lengthy discussions 
before ultimately deciding to adopt 
the “case/non-case” terminology.* 
The rationale for this decision was 
that the process that should be used 
by an ethics consultant—and there-
fore the specific competencies re-
quired—hinges on whether the eth-
ics consultation involves a question 
about a specific, active patient case, 
or instead involves a more general 
question such as how to interpret an 
ethics-related policy, how to under-
stand a particular ethics topic, or 
how to analyze a hypothetical or a 
historical (inactive) patient case. 
  
5.  Ethics facilitation approach 
clarified. Content related to the 
ethics facilitation approach to 
HCEC was clarified. For example, 
giving recommendations, sharing 
expertise, and use of mediation 
skills are consistent with an ethics 
facilitation approach. The term 
“pure facilitation” was replaced 
with “pure consensus” to more 
accurately describe the approach 
involving group agreement 
regardless of adherence to ethical 
standards.
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6.  Emerging ethics consultation 
service providers recognized. 
Newer models of ethics consultation 
services are briefly mentioned, 
such as regional ethics networks, 
consortia, and remote access 
services. 
7.  Emerging HCEC service and 
consultation process  standards 
added. The 2nd edition adds 
a new section on emerging 
process standards for HCEC—for 
example, having a policy on ethics 
consultation that specifies open 
access and a defined process for 
approaching a case consultation, 
such as holding a formal meeting 
with involved stakeholders (if 
appropriate), notifying the attending 
physician (if he/she was not aware 
that an ethics consultation was 
requested), and documenting 
the ethics consultation. This was 
thought appropriate given the 
evolution of the field over the years 
since the first edition of the Core 
Competencies report was published. 
 
8.  Skills table expanded. The 
following competencies were 
added to the ethics consultation 
skills table: quality improvement 
and evaluative skills; the ability 
to communicate and collaborate 
effectively with other responsible 
individuals, departments, or 
divisions within the institution; and 
the ability to access relevant ethics 
literature, policies, and guidelines. 
9.  Section on evaluating ethics 
consultations expanded. Section 3 
describes approaches to evaluating 
the quality (i.e., structure, process, 
and outcomes), access, and 
efficiency of an ethics consultation 
service. Where available, examples 
of empirical data on ethics 
consultation relating to each 
component are presented, as well 
as published tools to evaluate that 
component. Recommendations for 
evaluating and improving ethics 
consultation and priorities for future 
research are presented.
10.  “Character” changed to 
“attributes.” The content describing 
character traits that are desirable in 
ethics consultants was changed to 
“attributes, attitudes, and behaviors” 
of ethics consultants, as this is 
common language that health 
professions use to describe the 
behavioral component of practice.
 
11.  Ethical obligations and 
components of a code of ethics 
added. Based on efforts underway 
at the time of this publication to 
develop a code of ethics for health 
care ethics consultants, ethical 
obligations of such consultants are 
presented, along with implications 
for those functioning as professional 
ethics consultants.
* Resources from the VA’s 
National Center for Ethics in Health 
Care are prominently featured 
in the 2nd edition of the Core 
Competencies. In many instances, 
no other published resources were 
located that were as comprehensive 
as the VA’s. Of note, the staff at 
VA’s National Center for Ethics 
conducted a rigorous consensus 
development process that included 
systematic reviews and extensive 
input from multiple ASBH members 
representing many different 
organizations. 
The American Society for Bioethics and Humanities (ASBH) 
was founded in January 1998 through the consolidation of three 
existing associations in the field: the Society for Health and 
Human Values (SHHV), the Society for Bioethics Consultation 
(SBC), and the American Association of Bioethics (AAB). 
ASBH serves to promote the exchange of ideas and foster 
multidisciplinary, interdisciplinary, and inter-professional 
scholarship, research, teaching, policy development, and 
professional development among people engaged in bioethics 
and the health-related humanities. ASBH’s Clinical Ethics 
Consultation Affinity Group (CECAG) offers opportunities for 
individuals involved in clinical ethics to collaborate and share 
information. For more information about ASBH and CECAG, 
visit http://www.asbh.org. 
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CASE PRESENTATION
One of the regular features of this Newsletter is the presentation 
of a case considered by an ethics 
committee and an analysis of the 
ethical issues involved. Readers are 
both encouraged to comment on the 
case or analysis and to submit other 
cases that their ethics committee has 
dealt with. In all cases, identifying 
information about patients and others 
in the case should only be provided 
with the permission of the patient. 
Unless otherwise indicated, our 
policy is not to identify the submitter 
or institution. Cases and comments 
should be sent to MHECN@law.
umaryland.edu, or MHECN, Law & 
Health Care Program, University 
of Maryland School of Law, 500 W. 
Baltimore St., Baltimore, MD 21201.
CASE FROM A  
MARYLAND  
HOSPITAL*
GB is a woman with Stage IV cervical carcinoma that has spread to her lungs. 
She was so ill from her underlying 
disease that she was not considered a 
candidate for further chemotherapy.  
While she was hospitalized, three of 
her physicians spoke with her about 
the futility of further treatment and 
advised her to enter hospice care.  All 
three physicians documented in her 
chart the futility of further treatment 
other than comfort care.   She 
refused all consideration of Do Not 
Resuscitate/Do Not Intubate status.   
Upon discharge from the hospital, 
one of her physicians requested an 
ethics consultation out of concern 
that the patient was unrealistic about 
her medical condition. This physician 
wished to warn the emergency room 
(ER) staff about GB’s possible return 
to the ER in extremis, believing that  
attempts at full resuscitation would 
be inappropriate and would actually 
cause her more pain and suffering.
COMMENTS FROM  
A GERIATRICIAN
To my knowledge, there are no data available regarding how often physicians in Maryland 
utilize the provisions of the State's 
Health Care Decisions Act (HCDA)  
that allow a medical intervention to 
be withheld if two physicians certify 
that it is medically ineffective for 
a given patient (Sections 5-601 (n) 
and 5-611 (b)). The Act defines a 
procedure to be medically ineffective 
if  “to a reasonable degree of 
medical certainty, it will not prevent 
or reduce the deterioration of the 
health of an individual or prevent the 
impending death of an individual.”  
Orders for cardiac resuscitation 
procedures, commonly referred to as 
“Code Status Orders,” are typically 
written after discussion with the 
patient or surrogate decision maker, 
or upon review of the patient’s 
advance directives. The order either 
to attempt or withhold resuscitation 
efforts is usually entered with the 
consent of the patient him or her 
self, the surrogate decision maker 
or upon the authority of the valid 
written advance directive. How often 
physicians and patients disagree 
on whether cardiac resuscitation 
should be attempted is unknown. 
Generally, in today’s medical-
legal world, physicians will write 
“Full Code Status” orders at the 
request or insistence of the patient 
or surrogate decision maker, even 
when the physician believes Cardio-
Pulmonary Resuscitation (CPR) 
to be an ineffective procedure for 
saving the patient’s life. This reflects 
either the physician’s desire to 
respect the patient’s autonomous 
decision making, or to avoid the risk 
of potential legal action for writing 
a Do Not Resuscitate (DNR) order 
against the patient’s wishes, and/
or uncertainty about what really 
constitutes medical ineffectiveness 
in a legal sense. To my knowledge, 
no physician in Maryland has 
ever been sued for using medical 
ineffectiveness criteria for entering 
a DNR order against the expressed 
wishes of a patient or surrogate or 
written directive. But there is little 
comfort in this fact since, although 
there have been no prior lawsuits, 
there is fear of being the first case. 
There are anecdotal reports of 
hospital administrators, acting out 
of fear of legal action, preventing 
physicians from using medical 
ineffectiveness criteria to withhold 
requested treatment, even when the 
physician’s decision was supported 
by the deliberations of the hospital 
ethics committee. Data on the 
frequency of this sort of occurrence 
are lacking.
In the case presented above, the 
ethics committee was not asked 
to comment on the ethics of using 
medically ineffective criteria for 
withholding CPR against the wishes 
of the patient, but rather on whether 
the medically ineffective “No CPR” 
designation should be durable across 
sites of care. Does the “No CPR” 
order established during the acute 
hospital episode have durability if 
the patient should present to the 
emergency department at a later 
date?  Does it make a difference if 
this order were entered upon the 
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request of the patient, or rather by 
two physicians certifying that CPR 
would be medically ineffective? 
There are concrete logistical issues 
as well as ethical issues relevant to 
this case. 
If a patient in the community calls 
for emergency response via 911, 
the only way that the paramedics in 
Maryland will withhold CPR efforts 
is if a valid MEMS (Maryland 
Emergency Medical System) DNR 
form is presented. Therefore, a 
patient or family member who 
wishes to have CPR performed 
(even if the physicians believe 
it is ill advised) will simply not 
present the MEMS form and CPR 
will be implemented automatically, 
if the patient sustains sudden 
cardiac arrest in the presence of 
the paramedics. Once transported 
to the emergency department, 
the decision to continue or cease 
resuscitation efforts will most likely 
depend on the patient’s response to 
the initial efforts. The only way a 
DNR order would be honored in a 
community or ER setting would be 
if the patient presented with a valid 
MEMS form or personally gave the 
directive herself for no resuscitation. 
Logistically, if the patient was 
brought to the Emergency 
Department and was able to request 
full code status, the Emergency 
Department physician would not 
likely withhold CPR attempts, even 
if the anticipated outcome were 
death.
A study published in 2009 from 
The M.D. Anderson Cancer Hospital 
in Houston by Hwang et. al., re-
viewed all cancer patients sustaining 
cardiac arrest out of hospital treated 
in their emergency department be-
tween 2000 and 2002. Of the 41 pa-
tients undergoing CPR in the Emer-
gency Department, 18 (43%) had 
return of spontaneous circulation and 
were admitted to the intensive care 
unit.  Of those 18 patients, 9 did not 
survive the hospitalization and only 
two (4.9%) were discharged alive to 
home, the other 7 being discharged 
to other institutional care, such as an 
inpatient hospice or nursing facil-
ity. Short or long term survival data 
on the 9 CPR survivors were not 
presented. The patient may know 
the literature and may think that 5% 
odds are worth the attempt and argue 
that 5% success rate is medically ef-
fective when compared with the 0% 
success rate of doing nothing. The 
physicians might argue in response 
that this particular patient’s clinical 
status is much different from the two 
survivors in this study and that her 
likelihood of successful resuscitation 
is indeed much closer to zero.  How-
ever, all discussions of ineffective-
ness will be based upon probability 
statistics. Even the language of the 
HDCA is probabilistic in this regard, 
stating that “to a reasonable degree 
of medical certainty…. the procedure 
will not prevent or reduce deteriora-
tion or prevent impending death.”
Why do the physicians and 
patients, such as the one described in 
the case above, disagree on the issue 
of Cardiac Resuscitation? 
Causes of disagreement between 
patient and physician on the 
appropriateness of CPR may 
be grouped into the following 
categories:
1. Lack of patient education about 
the actual processes involved during 
CPR attempts and about the dismal 
outcomes of CPR for patients with 
advanced metastatic cancer;
2. Lack of patient opportunity 
to participate in advance care 
planning, to discuss goals of care and 
preferences for end of life care;
3. Distrust of the medical 
profession, with the perception that 
CPR would be withheld due to cost 
control concerns, rather than its 
ineffectiveness for the individual;
4. Fear that agreeing to DNR 
status is agreeing to a lesser level 
of medical attention prior to cardiac 
arrest;
5. Belief that a medical break-
through will occur and a cure will 
be achievable if only life can be 
extended until that time, thus giving 
up CPR is giving up the potential for 
living long enough for the medical 
breakthrough to occur;
6. Belief that a Divine Miracle 
will occur to restore health and 
wellness and that declining CPR will 
mean not living long enough for the 
miracle to become manifest;
7. Use of CPR as a concrete 
surrogate for hope, so that giving up 
CPR is equated with giving up hope.
Many physicians do not want 
to discuss prognosis and “do not 
resuscitate” orders with cancer 
patients due to a fear of “taking away 
the person’s hope.”  The clinical 
challenge, when caring for patients 
facing the end of life, is to present 
factual information on prognosis and 
what may be expected in the future 
while maintaining, but transitioning, 
the meaning of hope for individual 
patients. Hope at the end of life 
still deals with the future, despite a 
limited life expectancy. For some, 
hope is in the religious belief of a 
future afterlife, or simply the hope 
of finding peace in death, or going 
home in a sense. For others, hope 
resides in the future success of the 
children and grandchildren and the 
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Case Presentation
Cont. from page 7
continuation of the family. Hope 
may be found in reconciliation and 
forgiveness, and mending broken 
relationships, prior to death. One 
patient I cared for described her hope 
as the transition out of the sadness, 
knowing that she would no longer 
hear the ocean surf outside her 
window, into the joy she found in 
knowing that the sounds of the ocean 
surf would survive and continue 
on despite her absence.  For others, 
hope may be found in the relief of 
pain and having confidence that care 
will be present when needed as the 
end approaches, the promise of non-
abandonment.
Several years ago a patient of 
mine was diagnosed with pancreatic 
cancer. I performed his preoperative 
assessment prior to his Whipple 
procedure. After surgery, he enrolled 
in various chemotherapy protocols at 
the university cancer center and was 
lost to my follow up for one year. 
Then one day his wife called me in 
great distress. He had been dismissed 
from the cancer center because he 
was no longer responding to any of 
the protocols. He had been told to 
enroll in hospice. The patient was in 
pain and having anorexia, nausea, 
vomiting and profound weakness. I 
scheduled an urgent house call and 
found my patient not only cachectic, 
but actually cadaveric in appearance. 
He had lost a tremendous amount of 
weight, despite having cancer-related 
fluid retention and swelling in his 
abdomen and legs. He had low blood 
pressure. He was too weak to walk. 
He was ashen, pale and jaundiced. 
We discussed whether he would 
want to return to the hospital or have 
me call hospice and try to manage 
his symptoms at home. He opted for 
hospice care at home. We discussed 
cardiac resuscitation status. He was 
a retired physician and agreed that 
resuscitation would not benefit him 
at that point. He expressed his hope 
of being able to return to his native 
country before he died, though he 
realized this was unlikely. Comfort 
meds were ordered for the patient at 
home and the hospice nurse came 
on an urgent basis to enroll him 
that same day. As I left the home, 
his wife followed me out the door 
crying. She asked, “Is there no 
hope?” I responded that we could 
hope to get his symptoms under 
control very quickly and that he 
might have some peaceful time with 
his family gathered around him for 
his final hours or days. That night, 
he fell at home. The hospice nurse 
came back for an urgent visit. His 
breathing had become labored and 
the wife was not satisfied with his 
response to the comfort meds. She 
screamed at the hospice nurse, “Do 
something! Save him!” The wife 
called 911 and demanded that the 
hospice nurse start cardio-pulmonary 
resuscitation. When the paramedics 
arrived, they called their support 
physician and did not continue the 
resuscitation efforts. The patient 
died at home.  When I called the 
wife the following day, she said, 
“It all just happened so quickly.”  
Despite his yearlong illness and slow 
decline, she was totally unprepared 
for his death. She had, however, 
made arrangements for his body to 
be returned to his native country for 
burial, as was his wish.
Despite our best attempts to help 
our patients and their families accept 
the inevitability of death, some must 
rage against the dying of the light. 
Futile CPR attempts are the medical 
means of raging against the dying 
of the light. Demanding futile CPR 
efforts is the last stand of a false 
hope.  Physicians in Maryland have 
the authority to withhold procedures, 
including CPR efforts that are 
deemed medically ineffective. It is 
the duty of our profession, however, 
to help prepare our patients and their 
families for death through honest, 
ongoing discussion and education. 
We must help our patients find hope 
and integrity at the end of life. We 
must stop offering false hopes of 
the conquest of our very nature 
and humanity, of which death is as 
essential and important as birth. 
Rebecca D. Elon, MD, MPH
Associate Professor of Medicine
Johns Hopkins University
School of Medicine
Associate Medical Director
Gilchrist Hospice Care
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We need to be responsive to 
patients, families and care providers 
outside of the acute care hospital 
setting, given that much of health  
care is provided via short term  
hospitalization, in outpatient 
settings, or ultimately, at home. But,  
as in this particular scenario, the  
traditional ethics case consultation 
approach of meeting the patient  
and reviewing the medical record  
would have been problematic and   
insensitive. 
Instead of viewing this as an 
emergent ethical dilemma or conflict 
between the patient and physician 
that needed to be quickly resolved, 
the ethics consultant viewed the 
situation as non-emergent, and 
primarily a communication problem 
between the patient and the covering 
physician. The patient may have 
been unrealistic about her prognosis 
and the treatment  options available 
to her. However,  the  physician who 
requested the ethics consultation 
appeared to  harbor unrealistic 
expectations  about how much he 
could control other medical care 
providers’ actions if the patient 
presented to the  hospital emergency  
department, perhaps overruling the  
patient’s wishes and/or violating  
EMTALA guidelines.
Given  the  limitations  imposed  
by  the  facts of the case and those 
raised by Dr. Elon, our ethics com-
mittee took the  following  actions:
COMMENTS FROM 
THE ETHICS  
COMMITTEE CHAIR
This case, which came to our ethics consultation service, raises interesting 
questions about the role of an ethics 
consultant (individual or team) when 
responding to consultation requests.  
The patient’s primary physician was 
out of town.  The covering physician 
was adamant that the patient  not  
receive resuscitative attempts in a 
future presentation to the hospital. 
How should the ethics consultant 
handle such a request? Here is how 
our ethics consultation service 
responded. 
Since the patient had  already  left 
the hospital, it was not possible  
to meet with her and discuss the 
situation without making a trip to her 
home. The question of whether such 
a contact would violate HIPPA was 
raised, since HIPAA requires that 
the use and disclosure of protected 
health information be limited to 
what is needed in the course of 
providing medical care to a patient. 
HIPAA notwithstanding, the option 
of calling the patient at home was 
equally unappealing—imagine 
the patient, having just  returned 
home from the hospital  after this 
experience, being contacted by a 
consultant she did  not know/had 
not met, nor even been advised of, 
wanting to explore  these sensitive 
matters.
1)  We did not try to make contact  
with  the  patient  at  home.
2)  We did not request to see  the  
patient’s medical record at this time.
3)  We contacted the hospital  
administration, via the V.P. for  
Medical Affairs, to inform them of 
the  request for an ethics consultation 
by a treating physician and to gain  
permission to view the  patient’s 
medical record when/if it became  
necessary in the future.
4)  We explained to the physician 
who requested the ethics consultation 
the above considerations, reassuring 
him that we value his appreciation of 
this treatment dilemma, and  invited 
him  to  attend  the  next monthly 
meeting of our hospital Ethics  
Consultation Service, where we  
would fully discuss this case.
5) We thoroughly apprised the pa-
tient’s primary care physician of the 
situation at the first opportunity.   He 
thanked us for the call and  promised  
to talk with his patient.    
What ultimately happened? The  
patient entered hospice care and  
died a short time thereafter.  The  
covering physician did not attend our 
meeting.           
Terry Walman, MD, JD
Anne Arundel Medical Center
Annapolis, MD
.
10  Mid-Atlantic Ethics Committee Newsletter
“Closed defect.”
“V-P shunts.”
“Wheelchair.”
“Leg braces.”
“Incontinence.
”
“Intermittent catheterization.”
“Bowel regimen.”
“IQ points.”
“Bell-shaped curves.”
Drawings and a model seem to 
help, but I’m still not sure what they 
hear. For this family, I sense a lot of 
indecision and inner turmoil.
Our doctor asked if we’d be 
interested in a repair. Open the 
uterus, cover the hole, close the 
uterus, and continue the pregnancy? 
Our hearts lifted a little. 
The pediatric surgeon steps in. 
First he focuses on the technical as-
pects of prenatal surgery, then practi-
cal aspects like length of surgery, 
recovery time, complications for 
mother and fetus, and the absolute 
need for cesarean section for deliv-
ery. He discusses the research and 
outcomes for children with and with-
out in utero surgery. He states that 
this surgery is not a cure. It doesn’t 
reverse what already has happened, 
the fact that the neural tube didn’t 
NEVER AN ORDINARY DAY: 
STRUGGLES OF A PERINATOLOGIST 
Reprinted with permission from Atrium:  The Report of the Northwestern
Medical Humanities and Bioethics Program, Issue 7, 2009, pp. 26-27.
http://bioethics.northwestern.edu/atrium/
I prep the room before I call the family: I enlarge images of their fetus onto a 24” screen, 
I put tissues on the round table, 
and I put a plasticene model of a 
brain discreetly to the side so I can 
describe the pathophysiology of 
the defect when the time comes. 
The Smiths sit in the waiting room 
staring blankly at the TV.  Today 
they’ve had an ultrasound, fetal 
MRI, and fetal echocardiogram. I’m 
one of many strangers this couple 
has to meet, but our meeting is the 
day’s climax, the time when the 
pediatric surgeon and perinatologist 
(a high-risk obstetrician) will 
synthesize and distill all those 
test results. They look exhausted 
and apprehensive, but they smile 
tentatively as I usher them into the 
counseling room. 
Being a perinatologist is heart-
breaking. I love giving my patients 
information and answers. It may be  
difficult to hear but it gives families 
the knowledge, and sometimes even 
the strength, to take the next step. 
I hate that too often I’m giving the 
diagnosis and offering no options. 
I’m usually the bearer of bad news, 
and only sometimes the bearer of a 
tiny life preserver in an otherwise 
sinking ship. But now these consults 
represent the hope for a middle op-
tion that lies between “doing noth-
ing” and termination, the new option 
of fetal surgery.
Parents hope invasive fetal thera-
pies will be the “killer app” that 
can fix their fetuses. It’s my job to 
inform them these technologies and 
procedures aren’t always the solu-
tion. Mrs. Smith starts crying, and 
tears continue to well up throughout 
the entire session. She’s about 20 
weeks and the pregnancy isn’t a 
threat to her health, so if she wants 
to terminate she needs to decide fast. 
I ask the Smiths their understanding 
of the pregnancy and they speak as a 
team, trading sentences.
Everything was fine until a week 
ago when we had the ultrasound. 
We didn’t want to have any prenatal 
testing because we don’t believe in 
termination. The technician got quiet 
during the ultrasound and seemed 
uncomfortable; we could tell some-
thing wasn’t right. Then the doctor 
came in and told us there was a hole 
in the baby’s spine called spina bi-
fida. It seemed like forever before we 
could see our OB, and she confirmed 
it—our baby will have to wear dia-
pers forever, she’ll have problems 
walking, and she might have devel-
opmental, behavioral, and mental 
issues. There’s pulling on her spinal 
cord, so her brain’s affected. We felt 
so overwhelmed. 
I review the day’s radiologic 
findings with the family:
“Ventriculomegaly.”
“Myelomeningocele.”
“L3-L4.”
“Open defect.”
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close and the spinal cord has been 
exposed to amniotic fluid.
This couple is clearly looking for 
a miracle, but at what cost? I want 
to be sure Mrs. Smith doesn’t com-
promise her health unnecessarily, 
and that she understands the risks 
of what she might be undertaking. 
I want to be realistic but hopeful. 
I emphasize that the bottom line is 
that fetal surgery is still considered 
experimental. 
I’m uneasy. It’s hard to fathom 
the difficulty and enormity of their 
decision making. Mrs. Smith’s first 
pregnancy had been uncomplicated, 
this was going to be a little sister 
and their second daughter. After al-
most five months of carrying a preg-
nancy with many expectations and 
hopes, Mrs. Smith now faces an un-
certain future. I present the options 
and attempt to be non-directive, 
but I don’t think a physician can be 
truly objective and non-directive in 
counseling. We come to the table 
with our own morals and biases, our 
own life experiences, and our inti-
mate knowledge of the physiology 
and how it impacts normal bodily 
functions. We also know about the 
worst of the worst scenarios. There 
are no guarantees until birth, only a 
range of possibilities, and we can’t 
predict the impact each one will 
have on any particular family. No 
matter how many families I counsel, 
there is no way of conveying this 
intangible aspect. I can’t predict 
the future, and I can’t speak to the 
social, emotional or financial impact 
of their decisions. 
So far we’ve been discussing 
quality of life in terms of the medi-
cal model, fixing physical problems 
to fit into society’s understanding of 
“normal.” I introduce a discussion 
that this fetus and pregnancy could 
be another version of functioning 
and try to juxtapose the concept of 
disability with the focus on correc-
tion and cure. It isn’t an easy discus-
sion. The Smiths are quiet as they 
look at me; I’m not sure if they hear 
me. Their questions about ambula-
tion, incontinence, mental capacity 
and school leads me to believe they 
are trying to fit this possible real-
ity into their current life, and that 
makes sense—the families I see 
are generally focused on cure, not 
handicap. I’m not so different: years 
of medical training have taught me 
to think of the human body in terms 
of function and repair of function to 
normal too. 
The mothers I meet will usually 
sacrifice their health and body 
to achieve a chance of a cure. 
Acceptance of the disability 
usually isn’t made until after all 
curative options are exhausted and 
if termination is not an option. 
Nevertheless, I feel a need to raise 
the “social model of disability” in 
this meeting. It may seem odd to 
the Smiths, they came to us to hear 
about repair. I feel off-kilter myself 
since they haven’t made a decision 
yet. But if I don’t raise it now, who 
will? Most medical offices aren’t 
equipped to answer these questions 
or provide cogent answers. At the 
very least, we can provide resources 
and support if the families need 
information.
It’s exhausting. These counseling 
sessions weigh heavily upon me. 
My recommendation and descrip-
tion will influence a family decision 
that will alter their lives. I’ve never 
met these people before and this is 
probably the last time I’ll see them. 
I usually get one snapshot of their 
lives and family dynamic, and one 
chance at a coherent explanation of 
what’s going on. These strangers 
give me their trust, and in return I 
must use the power I hold respon-
sibly and balance the mother and 
family’s best interests. But what 
does that look like, exactly? I feel 
conflicted because the entire day’s 
focus is on the problem, its diagno-
sis and solution. I am not sure how 
to shift the focus beyond the “prob-
lem” and focus on the child.
Before the Smiths were able to 
decide on fetal surgery, that “middle 
option” was taken away from them 
—they didn’t qualify for the trial 
based upon the prenatal diagnostic 
images. Maybe that was devastat-
ing, maybe having one less decision 
to make made it easier—I wish I 
knew.
Parents come to me in varying 
degrees of understanding and 
denial. They come for hope (maybe 
the initial diagnosis was incorrect), 
for confirmation, and for the 
possibility that “something” can be 
done. I’ve counseled over a hundred 
families, and I still can’t imagine 
how my husband and I would react 
in the same situation. All I can do 
is continue to grapple with this 
quandary, and work to help families 
come to an understanding that 
encompasses all views, so they can 
make a truly informed choice.
Serena Wu, MD
Research Fellow in 
Fetal Biology and Therapy 
Children’s Hospital
of Philadelphia
Philadelphia, PA
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During the recent H1N1 pandemic, a variety of shortages – ranging 
from vaccines and antivirals to 
ventilators and ECMO machines1 
––have challenged our ability to 
provide prevention and treatment 
to everyone.  Governments, 
hospitals, and health-care providers 
have confronted difficult questions 
about who should receive scarce 
medical resources when not all can. 
In some cases, federal or state 
agencies have proposed or drafted 
allocation plans. The Centers for 
Disease Control and Prevention 
(CDC), for example, recommended 
priority access to the H1N1 
vaccine for five population groups 
at high-risk for complications 
from the illness.2   Similarly, 
Maryland prepared guidelines for 
the distribution of scarce H1N1 
antivirals,3 and New York drafted 
a scheme for ventilator allocation.4  
In many cases, however, decisions 
about how to ethically distribute 
limited resources during a 
pandemic have fallen to hospital 
ethics committees and health-care 
providers. What criteria should 
guide their determinations?
Historically, four allocation 
approaches have shaped decisions 
about how to ration limited 
medical resources. Each one can be 
described by the criteria it uses to 
select recipients of the scarce good: 
(1) social value criteria, 
(2) socio-medical criteria, 
(3) medical criteria, and 
(4) impartial criteria. 
THE PHILOSOPHER'S CORNER:
ALLOCATING SCARCE RESOURCES DURING PANDEMICS
Social value criteria.  Of the 
four criteria, distributing scarce 
resources on the basis of the 
potential recipients’ comparative 
value to society is the most 
controversial.  The best-known use 
of social value criteria dates back 
to 1962, when the Admissions and 
Policy Committee of the Seattle 
Artificial Kidney Center considered 
factors like prospective patients’ 
net worth, church attendance, 
and marital status in determining 
whether they ought to receive 
access to scarce dialysis machines.5 
The Committee was criticized 
for, among other things, “playing 
God,” reducing people to their 
social functions, and violating 
equal respect for persons. Today, 
ethicists generally eschew social 
value criteria, except in rare 
circumstances.6 
Socio-medical criteria. In 
contrast to social value criteria, 
which accord preference to 
prospective patients based on 
characteristics that have no bearing 
on medical outcomes, socio-
medical criteria grant priority status 
to prospective patients based on 
social and personal characteristics 
that arguably do impact health 
outcomes. Among other traits, 
socio-medical criteria may include 
a person’s age, lifestyle, mental 
health, history of responsible 
behavior, and likelihood of 
complying with medical regimens. 
Socio-medical criteria have 
gained some traction in modern 
medicine, particularly in the 
context of organ transplantation 
policy. People with strong social 
support systems––and who are 
young, psychologically stable, 
and medically responsible––are 
considered “better” candidates 
for organ transplantation than 
those who do not possess these 
characteristics. Applying socio-
medical criteria to determine 
allocation can, however, deprive 
some people of fair and equal 
access opportunities. For that 
reason, medical or impartial criteria 
(discussed below) often are viewed 
as more ethically sound approaches 
to distributing scarce resources.7 
Medical criteria. The American 
Medical Association’s (AMA) 
Code of Ethics recommends 
medical criteria as the “only 
ethically appropriate criteria” 
for allocating limited medical 
resources.8  Accordingly, allocation 
decisions can consider the 
prospective patient’s “likelihood 
of benefit, urgency of need, change 
in quality of life, duration of 
benefit, and, in some cases, the 
amount of resources required for 
successful treatment.”9  Medical 
criteria inform the CDC’s 
H1N1 vaccination scheme, 
which recommends vaccinating 
populations at the highest risk for 
H1N1-related illness first.10  New 
York’s ventilator allocation plan,11  
which provides ventilator access 
to patients who “have the greatest 
medical need—and the best 
chance of survival—if they receive 
ventilator support,” also employs 
medical criteria.
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Impartial criteria. The AMA 
Code of Ethics suggests that when 
there are not significant differences 
between patients on the basis of 
medical criteria, resources should 
be allocated randomly among 
eligible candidates.  There are 
a variety of equal-opportunity 
creating mechanisms, including 
queuing (first-come-first-served) 
and chance (lottery) systems. 
During the 2004 flu season, 
queuing and lotteries were used 
to distribute the flu vaccine, 
which was in short supply due 
to production mishaps. Limited 
supplies of drugs to treat AIDS 
have been similarly distributed to 
patients.12  Advocates of impartial 
allocation highlight the fact that 
it treats all persons fairly and 
equally.13  Detractors “contend that 
the use of impersonal mechanisms 
reflects an irresponsible refusal to 
make a decision,”14  and that the 
mechanisms themselves can create 
unintentional injustices.15  
Hospitals and ethics committees 
have adopted a variety of 
approaches to allocating scarce 
resources during the H1N1 
pandemic. It is still too early 
to determine which criteria are 
in greatest use, though early 
evidence suggests a preference 
for medical criteria.16  Regardless, 
it is important to note that these 
criteria require careful application 
and transparent execution. Reports 
suggest that the H1N1 flu season 
may be ending, but conversations 
about how to ethically steward our 
scarce resources must continue.
Leslie Meltzer Henry
Assistant Professor of Law
University of Maryland
School of Law
Baltimore, MD
NOTES
1ECMO stands for Extracorporeal 
Membrane Oxygenation. It is a 
form of cardiac and respiratory sup-
port for a patient whose heart and 
lungs are not functioning properly.
2CDC, 2009 H1N1 Vaccination 
Recommendations (2009), available 
at http://www.cdc.gov/h1n1flu/vac-
cination/acip.htm.
3Maryland Department of Health 
and Mental Hygiene, Pandemic 
Influenza Response Annex (Version 
7.3, 2009), available at http://bioter-
rorism.dhmh.state.md.us/Docs/Pan-
demicInfluenza/PandemicInfluenzaR
esponseAnnex(Version7.3).pdf.
4New York State Working Group on 
Ventilator Allocation in an Influenza 
Pandemic, Allocation of Ventilators 
in a Pandemic: Planning Document 
(2007), available at http://www.
health.state.ny.us/diseases/commu-
nicable/influenza/pandemic/ventila-
tors/docs/ventilator_guidance.pdf.
5Shana Alexander, “They Decide 
Who Lives, Who Dies,” 53 Life 
102-125 (1962).
6During World War II, scarce doses 
of penicillin were administered 
to soldiers who had contracted 
venereal diseases rather than 
soldiers who had infected battle 
wounds. The rationale was that the 
former could return to the battlefield 
more rapidly. Tom L. Beauchamp 
and James F. Childress, Principles 
of Biomedical Ethics 270 (5th ed. 
2001).
7Id. at 267.
8Code of Medical Ethics §2.03, 
http://www.ama-assn.org/ama/pub/
physician-resources/medical-ethics/
code-medical-ethics/opinion203.
shtml.
9Id.
10See supra note 2.
11New York State Department of 
Health and the New York State 
Task Force on Life & the Law, New 
York State Workgroup on Ventilator 
Allocation in an Influenza Pandemic 
(2007), http://www.ama-assn.org/
ama1/pub/upload/mm/415/new_
york_state.pdf.
12Beauchamp and Childress, supra 
note 6, at 268. 
13Id.
14Id.
 
15For example,  the rule of first-
come-first-served can raise ques-
tions about whether patients already 
receiving treatment have priority 
over prospective patients who ar-
rive later but may have either more 
urgent medical needs or a better 
prognosis with treatment. 
16In particular, many hospitals 
are adopting a clinical algorithm, 
known as SOFA scoring, for 
allocating limited resources on the 
basis of standard medical criteria.
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CALENDAR OF EVENTS
MARCH
17  (12:15 PM – 1:15 PM) Howard B. Mayes’ lecture in ethics.   Speaker:  Danielle Aubrey, MD.
 University of Maryland Medical Center, Shock Trauma Auditorium, 22 S. Greene St., Baltimore, 
 MD. For more information, contact Henry Silverman at hsilverm@medicine.umaryland.edu. 
26 “Health Law and the Elderly: Managing Risk at the End of Life,” sponsored by the Widener 
 Law Review, in partnership with the Widener University School of Law Health Law Institute,
  Delaware Hospice, the Delaware End-of-Life Coalition, at the Ruby Vale Courtroom on 
 Widener’s Wilmington, Delaware campus. For more information, visit http://widenerlawreview.
 org/?page_id=329 or contact Thaddeus Pope at tmpope@widener.edu.
APRIL
6  (4:00 PM – 6:00 PM)  Seminar Speaker: Stephen Latham, JD, PhD, Deputy Director, 
 Interdisciplinary Center for Bioethics, Yale University. Sponsored by the University of 
 Pennsylvania Center for Bioethics, 3401 Market St, Suite 331, Philadelphia, PA. For more 
 information, visit http://bioethics.upenn.edu/Colloquium.shtml. To RSVP, e-mail 
 jpringle@mail.med.upenn.edu or call 215-898-7136.
8 (12:00 noon) “Futility:  What’s a Doctor to Do?”  Grand Rounds, Shady Grove Adventist 
 Hospital.  Speaker:  Paul S. Van Nice, MD, PhD, MA.  Complimentary lunch.  Birch/Sycamore 
 Conference Rooms, Shady Grove Adventist Hospital, 9901 Medical Center Drive, Rockville, 
 MD 20850.  For more information, contact paul@vannice.com.
12  (12:15 PM – 1:15 PM)  Rives Hutzler Lecture:  Speaker, Alan Fleischman, MD, Senior Vice 
 President, New York Academy of Medicine. Sponsored by the Berman Institute of Bioethics, 
 Johns Hopkins University, 615 N. Wolfe Street, W3008. For more information, visit http://www.
 bioethicsinstitute.org/, or contact Michelle Martin-Daniels at atmmartind@jhsph.edu.
12  (5:30PM - 7:00PM)   “Medical Miracles: Doctors, Saints and Healing in the Modern World,” 
 the John K. Lattimer Lecture.  Speaker: Jacalyn Duffin, MD, PhD, Queen’s University. 
 Sponsored by the New York Academy of Medicine, 1216 Fifth Avenue, New York, NY. For
 more information, visit http://www.nyam.org/events/.
19 “Health Care Ethics in the 21st Century,” Providence Health Care’s 2nd Annual Health Ethics 
 Seminar, Conference Centre, 2nd Floor, 1190 Hornby St, Vancouver, BC. For more information, 
 visit http://www.providencehealthcare.org/ethics_services/, e-mail jmonthatawil@providence
 health.bc.ca, or call 604-806-9952.
19-20 “Recognizing and Managing Moral Distress in Rehabilitation Health Care.” Sponsored by the 
 Rehabilitation Institute of Chicago, Chicago, IL. For more information, visit http://www.ric.org/
 education. 
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22-24 “Pediatric Ethics 2010: Advancing the Interests of Children,” sponsored by the Northern Ohio 
 Regional Pediatric Ethics Consortium. Cleveland Renaissance, Cleveland, OH. For more 
 information, visit www.ccfcme.org/PediatricEthics10, or contact Kathryn Wiese at 
 WEISEK@ccf.org. 
26  (12:15 PM – 1:15 PM)  Berman Institute of Bioethics Lunch Seminar Series Speaker:  Karen 
 Rothenberg, JD, MPA, Marjorie Cook Professor of Law, University of Maryland School of Law, 
 Visiting Faculty, Johns Hopkins Berman Institute of Bioethics. Sponsored by the Berman Institute 
 of Bioethics, Johns Hopkins University, 615 N. Wolfe Street, W3008. For more information, visit 
 http://www.bioethicsinstitute.org/, or contact Michelle Martin-Daniels at atmmartind@jhsph.edu.
10 (12:15 PM – 1:15 PM)  Berman Institute of Bioethics Lunch Seminar Series Speaker: Peter 
 Whitehouse, MD, PhD, Professor of Neurology, Case Western Reserve University. Sponsored by 
 the Berman Institute of Bioethics, Johns Hopkins University, 615 N. Wolfe Street, W3008, 
 Baltimore, MD. For more information, visit http://www.bioethicsinstitute.org/, or contact Michelle 
 Martin-Daniels at atmmartind@jhsph.edu.
28 “Disability, Health Care, and Clinical Ethics—What Really Matters.” Co-sponsored by MHECN
 and Kennedy Krieger Institute, at Thomas B. Turner Building, Johns Hopkins University 
 School of Medicine, 720 Rutland Avenue, Baltimore, MD.  For more information and to register 
 online, visit http://www.law.umaryland.edu/mhecn (click on “conferences”). Or e-mail 
 MHECN@law.umaryland.edu.
29  (10:30AM – 12:30 PM)  “A Deeper Diversity, The Nation’s Health: Renewing Social Justice 
 and Human Well-Being in Our Time.” Sponsored by the Office of Sponsored Projects of the 
 Smithsonian Institution in partnership with the Navy Medicine Institute for the Medical 
 Humanities and Research Leadership. National Museum of American History, Smithsonian 
 Institution, Washington, DC. For more information, visit http://www.thechiefinformationgroup.
 com/conference/smithsonian/index.php?c_id=12, or contact Julie O'Dell at O'DellJ@si.edu.
MAY
6-7 “Intensive Workshop in Healthcare Ethics” Sponsored by the University of Arkansas Medical 
 System, Little Rock, AR. For more information, visit http://www.uams.edu/humanities/HCE-
 2010.asp, or contact Carol VanPelt at vanpeltcarola@uams.edu. 
11-14 “6th International Conference on Clinical Ethics Consultation” (ICCEC), Portland, OR. For more 
 information, visit http:// www.ethics2010.org.
13  (4:00 PM – 6:00 PM)  Seminar Speaker: Rita Charon, MD, PhD, Professor of Clinical Medicine, 
 Director, Program in Narrative Medicine, College of Physicians and Surgeons of Columbia 
 University. Sponsored by the University of Pennsylvania Center for Bioethics, 3401 Market St, 
 Suite 331, Philadelphia, PA. For more information, visit http://bioethics.upenn.edu/Colloquium.
 shtml. To RSVP, e-mail jpringle@mail.med.upenn.edu or call 215-898-7136.
21-22 “Disability and Ethics through the Life Cycle: Cases, Controversies, & Finding Common Ground.” 
 Sponsored by Albany Law School, the Rapaport Ethics Across the Curriculum Program of Union 
 College, and the Bioethics Program of Union Graduate College and the Mount Sinai School of 
 Medicine. Union College, Schenectady, NY. For more information, contact blooma@union.edu or 
 noltea@uniongraduatecollege.edu.
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